1
2
3

Good news! Wuxi Beta Pharmaceutical Technology Co., Ltd. was recognized as a "high-tech enterprise" for the third time"

Release time:

2021-01-28

On January 22, 2021, the Office of the National High-tech Enterprise Certification Management Leading Group issued the "Reply on the Filing of the First Batch of High-tech Enterprises in Jiangsu Province in 2020" (Guo Ke Huo [2021] No. 39), Wuxi Beta Pharmaceutical Technology Co., Ltd. was recognized as a "high-tech enterprise" (ranked 4962). This is the third time that our company has been recognized as a "high-tech enterprise". Wuxi Beta Pharmaceutical Technology Co., Ltd. was founded in Jiangyin High-tech Zone on November 27, 2008 by Dr. Li Gang, winner of the second prize for national scientific and technological progress and an entrepreneurial talent studying in the United States. It is a high-tech private enterprise specializing in the research and development and industrialization of isotope labeling products and tracer technologies such as carbon -14(C14) and carbon -13(C13) in the field of nuclear technology application (isotope) in China, the main purpose is to apply the strategic nuclide C14 radioisotope labeling tracer technology to innovative medicine, pesticide research and development, biotechnology and medical testing. The company has 4000 square meters of isotope labeling laboratory, and has established research and development platforms such as the Nobel Prize Research Institute, "Jiangsu Enterprise Academician Workstation" and Jiangyin Beta Isotope Labeling Engineering Technology Research Center. It has 18 authorized technology patents and more than 400 isotope labeling products, most of which fill the gaps in China and some of which are international initiatives. The company has signed cooperation agreements with nuclear reactor units, domestic and foreign pharmaceutical and pesticide industry leaders, Cambridge isotope laboratory company of the United States, Swiss RCTRITECH company, etc., after more than ten years of technical research, it has created five "gold standard" products and technologies in the field of medicine and medical treatment. Especially in the field of C14 marking products and tracer technology, the localization of domestic C14 source materials has been realized for the first time, and the C14 marking of domestic innovative medicines and pesticides has been solved. C14 marking services have been provided to listed pharmaceutical and pesticide companies such as Hengrui Medicine, Koren Pharmaceutical and Lier Chemical, as well as dozens of leading pharmaceutical and pesticide metabolism units such as Shanghai Institute of Medicine, Chinese Academy of Sciences, Ecological Environment Research Center and Shenyang Institute of Chemical, widely praised by customers, it has doubled the growth of its main business for three consecutive years and established solutions for international shortages. The identification of "high-tech enterprise" is a recognition of Wuxi Beta's long-term focus on research and development and rapid growth. Beta people will forge ahead and make new achievements, making unique and important contributions to the development of innovative medicine, innovative pesticide and ecological environmental protection.

On January 22, 2021, the Office of the National High-tech Enterprise Certification Management Leading Group issued the "Reply on the Filing of the First Batch of High-tech Enterprises in Jiangsu Province in 2020" (Guo Ke Huo [2021] No. 39), Wuxi Beta Pharmaceutical Technology Co., Ltd. was recognized as a "high-tech enterprise" (ranked 4962). This is the third time that our company has been recognized as a "high-tech enterprise".

Wuxi Beta Pharmaceutical Technology Co., Ltd. is composed of Dr. Li Gang, the second prize winner of the National Science and Technology Progress Award and a returnee entrepreneurial talent studying in the United States.2008Year11Month27Founded in Jiangyin High-tech Zone, Japan is a domestic nuclear technology application (isotope) field specializing in carbon-14（C14) and carbon-13（C13) and other isotope labeling products and tracer technology research and development and industrialization of high-tech private enterprises, mainly the strategic nuclide.C14Radioisotope labeling tracer technology is used in innovative medicine, pesticide research and development, biotechnology and medical testing.

The company's existing4000Square meters of isotope labeling laboratory, the establishment of the Nobel Prize Research Institute, "Jiangsu Province Enterprise Academician Workstation", Jiangyin Beta Isotope Labeling Engineering Technology Research Center and other research and development platforms, with authorized technology patents.18Item, isotope-labeled products400A variety of, mostly to fill the domestic gap, some for the international initiative. The company and nuclear reactor units, domestic and foreign pharmaceutical and pesticide industry leaders, the United States Cambridge Isotope Laboratories, Switzerland.RCTRITECHCompanies and others have signed cooperation agreements, and after more than ten years of technical research, they have created five "gold standard" products and technologies in the pharmaceutical and medical fields. especially inC14For the first time in the field of marking products and tracer technology, the domesticC14The localization of source materials solves the problem of domestic innovative pharmaceuticals and innovative pesticides.C14The state of marking sent abroad to do is provided for listed pharmaceutical and pesticide companies such as Hengrui Pharmaceutical, Koren Pharmaceutical and Lier Chemical, as well as dozens of pharmaceutical and pesticide metabolism leading units such as Shanghai Institute of Medicine, Chinese Academy of Sciences, Ecological Environment Research Center of Chinese Academy of Sciences, Shenyang Research Institute of Chemical Industry, etc.C14Marking services, widely praised by customers, has doubled the growth of the main business for three consecutive years, and has established a solution for the international shortage.

This timeThe recognition of "high-tech enterprise" is a recognition of Wuxi Beta's long-term focus on research and development and rapid growth. Beta people will forge ahead and make new achievements, making unique and important contributions to the development of innovative medicine, innovative pesticide and ecological environmental protection.

Previous

Lu Jun, vice chairman of Wuxi Association for Science and Technology, and his party came to Beta Medicine for investigation and investigation.

Our company was selected as a reserve enterprise for cultivating science and technology innovation board in Jiangyin city in 2020.

Next

Previous

Lu Jun, vice chairman of Wuxi Association for Science and Technology, and his party came to Beta Medicine for investigation and investigation.

Next

Our company was selected as a reserve enterprise for cultivating science and technology innovation board in Jiangyin city in 2020.